Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 9 | 2023 | 633 | 1.180 |
Why?
|
| Cartilage, Articular | 7 | 2019 | 419 | 0.920 |
Why?
|
| Tendon Injuries | 5 | 2014 | 205 | 0.890 |
Why?
|
| Knee Injuries | 5 | 2014 | 204 | 0.810 |
Why?
|
| Rotator Cuff | 4 | 2014 | 308 | 0.790 |
Why?
|
| Tissue Engineering | 2 | 2012 | 31 | 0.750 |
Why?
|
| Arthroplasty, Replacement, Hip | 7 | 2023 | 805 | 0.730 |
Why?
|
| Platelet-Rich Plasma | 6 | 2017 | 85 | 0.630 |
Why?
|
| Osteoarthritis, Knee | 5 | 2021 | 373 | 0.590 |
Why?
|
| Arthroscopy | 8 | 2019 | 1105 | 0.550 |
Why?
|
| Transplantation, Homologous | 4 | 2014 | 279 | 0.540 |
Why?
|
| Knee Joint | 6 | 2023 | 760 | 0.530 |
Why?
|
| Rotator Cuff Injuries | 5 | 2014 | 316 | 0.520 |
Why?
|
| Knee Prosthesis | 1 | 2019 | 224 | 0.510 |
Why?
|
| Biomechanical Phenomena | 2 | 2011 | 643 | 0.390 |
Why?
|
| Orthopedic Procedures | 3 | 2012 | 314 | 0.390 |
Why?
|
| Arthralgia | 1 | 2013 | 135 | 0.380 |
Why?
|
| Arthritis, Infectious | 2 | 2023 | 50 | 0.370 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 44 | 0.370 |
Why?
|
| Retrospective Studies | 10 | 2023 | 3551 | 0.340 |
Why?
|
| Humans | 28 | 2023 | 27307 | 0.340 |
Why?
|
| Prosthesis-Related Infections | 2 | 2023 | 187 | 0.320 |
Why?
|
| Quality of Life | 1 | 2013 | 631 | 0.300 |
Why?
|
| Hyaluronic Acid | 3 | 2017 | 55 | 0.280 |
Why?
|
| Reoperation | 4 | 2022 | 921 | 0.280 |
Why?
|
| Shoulder | 3 | 2015 | 188 | 0.270 |
Why?
|
| Middle Aged | 12 | 2019 | 9068 | 0.250 |
Why?
|
| Male | 14 | 2022 | 14887 | 0.250 |
Why?
|
| Female | 14 | 2022 | 15334 | 0.240 |
Why?
|
| Adult | 9 | 2019 | 7945 | 0.230 |
Why?
|
| Young Adult | 7 | 2019 | 2032 | 0.230 |
Why?
|
| Urinary Retention | 1 | 2022 | 13 | 0.200 |
Why?
|
| Risk | 2 | 2023 | 205 | 0.200 |
Why?
|
| Tibial Meniscus Injuries | 2 | 2014 | 86 | 0.200 |
Why?
|
| Cholecalciferol | 1 | 2022 | 7 | 0.200 |
Why?
|
| Wound Healing | 2 | 2015 | 159 | 0.200 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 33 | 0.200 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 32 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2023 | 46 | 0.190 |
Why?
|
| Orthopedic Surgeons | 1 | 2022 | 27 | 0.190 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 79 | 0.190 |
Why?
|
| Injections, Intra-Articular | 5 | 2022 | 93 | 0.190 |
Why?
|
| Menisci, Tibial | 2 | 2014 | 173 | 0.180 |
Why?
|
| Shoulder Impingement Syndrome | 2 | 2011 | 14 | 0.180 |
Why?
|
| Polyethylene | 2 | 2019 | 124 | 0.180 |
Why?
|
| Surgeons | 2 | 2019 | 88 | 0.180 |
Why?
|
| Absorbable Implants | 2 | 2011 | 27 | 0.170 |
Why?
|
| Prosthesis Design | 2 | 2019 | 483 | 0.170 |
Why?
|
| Joint Diseases | 1 | 2021 | 116 | 0.160 |
Why?
|
| Pain Measurement | 3 | 2022 | 486 | 0.160 |
Why?
|
| Fractures, Stress | 1 | 2019 | 21 | 0.150 |
Why?
|
| Prosthesis Failure | 2 | 2019 | 520 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2019 | 45 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 177 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2019 | 277 | 0.150 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2019 | 75 | 0.140 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 675 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2019 | 151 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2019 | 334 | 0.140 |
Why?
|
| Adolescent | 5 | 2014 | 2185 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 1108 | 0.130 |
Why?
|
| Joint Instability | 2 | 2011 | 395 | 0.130 |
Why?
|
| Aged | 6 | 2019 | 9120 | 0.130 |
Why?
|
| Rupture | 2 | 2014 | 111 | 0.130 |
Why?
|
| Tibia | 1 | 2019 | 246 | 0.130 |
Why?
|
| Synovial Fluid | 1 | 2016 | 92 | 0.130 |
Why?
|
| Chondrogenesis | 1 | 2015 | 32 | 0.120 |
Why?
|
| Arthroplasty, Subchondral | 1 | 2015 | 30 | 0.120 |
Why?
|
| Cartilage | 2 | 2014 | 103 | 0.110 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 513 | 0.110 |
Why?
|
| Achilles Tendon | 1 | 2014 | 14 | 0.110 |
Why?
|
| Acromion | 1 | 2014 | 28 | 0.110 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 1 | 2014 | 34 | 0.110 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 34 | 0.110 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 37 | 0.110 |
Why?
|
| Hip Prosthesis | 1 | 2019 | 535 | 0.110 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2013 | 17 | 0.110 |
Why?
|
| Patellar Ligament | 1 | 2014 | 43 | 0.110 |
Why?
|
| Synovial Membrane | 1 | 2013 | 56 | 0.110 |
Why?
|
| Range of Motion, Articular | 2 | 2014 | 720 | 0.100 |
Why?
|
| Muscle Strength | 1 | 2013 | 131 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 110 | 0.100 |
Why?
|
| Artificial Cells | 1 | 2012 | 2 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2013 | 303 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2012 | 46 | 0.090 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2011 | 17 | 0.090 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 157 | 0.090 |
Why?
|
| Athletic Injuries | 1 | 2013 | 175 | 0.090 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2012 | 196 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2016 | 3540 | 0.080 |
Why?
|
| Suture Anchors | 1 | 2011 | 101 | 0.080 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 1 | 2012 | 201 | 0.080 |
Why?
|
| Sutures | 1 | 2010 | 54 | 0.080 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1807 | 0.080 |
Why?
|
| Tendons | 1 | 2011 | 221 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2010 | 160 | 0.080 |
Why?
|
| Osteoarthritis | 1 | 2013 | 335 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2016 | 1792 | 0.080 |
Why?
|
| Shoulder Injuries | 1 | 2010 | 145 | 0.080 |
Why?
|
| Pain, Postoperative | 2 | 2022 | 316 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2022 | 408 | 0.080 |
Why?
|
| Shoulder Joint | 2 | 2011 | 657 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 597 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2023 | 930 | 0.060 |
Why?
|
| Iatrogenic Disease | 1 | 2023 | 25 | 0.050 |
Why?
|
| Urinary Catheters | 1 | 2022 | 5 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2022 | 8 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 18 | 0.050 |
Why?
|
| Clonidine | 1 | 2022 | 17 | 0.050 |
Why?
|
| Ketorolac | 1 | 2022 | 12 | 0.050 |
Why?
|
| United States | 2 | 2022 | 2078 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2022 | 19 | 0.050 |
Why?
|
| Epinephrine | 1 | 2022 | 31 | 0.050 |
Why?
|
| Risk Factors | 2 | 2023 | 2335 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2022 | 65 | 0.050 |
Why?
|
| Bupivacaine | 1 | 2022 | 45 | 0.050 |
Why?
|
| Vitamin D | 1 | 2022 | 37 | 0.050 |
Why?
|
| Morphine | 1 | 2022 | 72 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2022 | 24 | 0.050 |
Why?
|
| Arthroplasty | 1 | 2022 | 159 | 0.040 |
Why?
|
| Postural Balance | 1 | 2022 | 116 | 0.040 |
Why?
|
| Radiography | 2 | 2014 | 617 | 0.040 |
Why?
|
| Pain Management | 1 | 2022 | 143 | 0.040 |
Why?
|
| Social Class | 1 | 2021 | 64 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 230 | 0.040 |
Why?
|
| Office Visits | 1 | 2019 | 11 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 416 | 0.040 |
Why?
|
| Outpatients | 1 | 2019 | 59 | 0.040 |
Why?
|
| Time Factors | 2 | 2014 | 1444 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2019 | 137 | 0.040 |
Why?
|
| Hospitals | 1 | 2019 | 170 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 125 | 0.040 |
Why?
|
| Lysholm Knee Score | 1 | 2016 | 8 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 12 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 20 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 26 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 111 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 180 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 80 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 197 | 0.030 |
Why?
|
| Acupuncture | 1 | 2013 | 2 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2013 | 6 | 0.030 |
Why?
|
| Viscosupplementation | 1 | 2013 | 6 | 0.030 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2013 | 20 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 33 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 53 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2013 | 57 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 92 | 0.030 |
Why?
|
| Aggrecans | 1 | 2013 | 54 | 0.030 |
Why?
|
| Collagen | 1 | 2013 | 86 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2013 | 75 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 146 | 0.030 |
Why?
|
| Debridement | 1 | 2013 | 104 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 77 | 0.030 |
Why?
|
| Allografts | 1 | 2014 | 216 | 0.030 |
Why?
|
| Gene Expression | 1 | 2013 | 201 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 193 | 0.020 |
Why?
|
| Time-to-Treatment | 1 | 2012 | 34 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 97 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2012 | 18 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2012 | 36 | 0.020 |
Why?
|
| Leukocytes | 1 | 2012 | 35 | 0.020 |
Why?
|
| Ceramics | 1 | 2011 | 20 | 0.020 |
Why?
|
| Benzophenones | 1 | 2011 | 25 | 0.020 |
Why?
|
| Ketones | 1 | 2011 | 23 | 0.020 |
Why?
|
| Synovitis | 1 | 2011 | 22 | 0.020 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2012 | 183 | 0.020 |
Why?
|
| Polymers | 1 | 2011 | 42 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 42 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 89 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2012 | 352 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 425 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 779 | 0.020 |
Why?
|
| Osteolysis | 1 | 2011 | 139 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 4841 | 0.020 |
Why?
|
| Child | 1 | 2012 | 1269 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 3681 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1903 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 1156 | 0.010 |
Why?
|